Oral candidosis as a clinical marker of immune failure in patients with HIV/AIDS on HAART

AIDS Patient Care and STDs

Volumn 19, Issue 2, 2005, Pages 70-77

  Gaitán Cepeda, Luis Alberto ^a,c   Martínez González, Mario ^a   Ceballos Salobreña, Alejandro ^b  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b UNIVERSITY OF GRANADA   (Spain)

^c Div Estud de Postgrado e Invest   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; DISEASE CONTROL; DISEASE COURSE; DISEASE MARKER; DRUG RESPONSE; DRUG USE; FEMALE; HETEROSEXUALITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOPATHOLOGY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MOUTH EXAMINATION; RISK ASSESSMENT; SEX DIFFERENCE; SPAIN; THRUSH; TREATMENT FAILURE; VIRUS LOAD; VIRUS TRANSMISSION; WORLD HEALTH ORGANIZATION;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANALYSIS OF VARIANCE; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CANDIDIASIS, ORAL; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HUMANS; LEUKOPLAKIA, HAIRY; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; RISK FACTORS; TREATMENT FAILURE; VIRAL LOAD;

EID: 14344257634     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2005.19.70     Document Type: Article

References (25)

1. UNAIDS. Report on the Global HIV/AIDS. Switzerland UNAIDS, 2002.
2. Mellors JW, Rinaldo CR Jr, Gupta P, White RM, Todd JA, Kinsley L. Prognosis of HIV-1 contagious predicted by the quantity of virus in plasma. Science 1996;272:1167-1170.
3. Vlahov D, Graham N, Hoover D, et al. prognostic indicators for AIDS and contagious disease death in HIV-infected drug users. JAMA 1998;279:35-40.
4. Glick M, Música BC, Curie D, Salkin L. Oral manifestations associated with HIV-related disease as markers for immune suppression and AIDS. Oral Surg Oral Med Oral Pathol 1994;77:344-349.
5. Kolokotronis A, Dioses V, Antoniades D, Mandraveli K, Doutsos I, Papanayotou P: Immunologic status in patients infected with HIV with oral candidiasis and hairy leukoplakia. Oral Surg Oral Med Oral Pathol 1994;78:41-46.
6. Schmidt-Westhausen A, Grunewald T, Reichert PA, Pohle HD. Oral manifestations in 70 German HIV-infected women. Oral Dis 1997;3(Suppl. 1):S28-S30.
7. Ramirez-Amador VA, Esquivel-Pedraza L, Ponce de Leon S, Ponce de Leon S. Prognostic value of oral Candidosis and hairy Leukoplakia in 111 Mexican HIV-infected patients. J Oral Pathol Med 1996;25:206-211.
8. Cauda R, Tacconelli E, Tumbarello M, et al. Role of protease inhibitors in preventing recurrent oral candidosis in patients with HIV contagious: A prospective case-control study. J Acquir Immune Defic Syndr 1999;21:20-25.
9. Patton LL, Mckaig R, Strauss R, Rogers D, Eron JJ. Changing prevalence of oral manifestations of human immunodeficiency virus in the era of protease inhibitor therapy. Oral Surg Oral Med Oral Pathol 2000;89:299-304.
10. Ceballos-Salobreña A, Gaitan-Cepeda LA, Ceballos-Garcia L, Lezama Del Valle D. Oral lesions in HIV/AIDS patients undergoing highly active antiretroviral treatment including protease inhibitors: A new face of oral AIDS. AIDS Patient Care STD 2000;14:627-635.
11. Tappuni AR, Fleming GJ. The effect of antiretroviral therapy on the prevalence of oral manifestations in HIV-infected patients: A UK study. Oral Surg Oral Med Oral Pathol 2001;92:623-628.
12. Classification and diagnostic criteria for oral lesions in HIV contagious. EC-Clearinghouse on Oral Problems Related to HIV Infection and WHO Collaborating Centre on Oral Manifestations of the Immunodeficiency Virus: J Oral Pathol Med 1993;22:289-291.
13. Gottlieb MS, Schroff R, Schanker HM, et al: Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: Evidence of a new acquired cellular immunodeficiency. N Engl J Med 1981;305:1425-1431.
14. Patton LL, Phelan JA, Ramos-Gomez FJ, Nittayananta W, Shiboski CH, Mbuguye TL. Prevalence and classification of HIV-associated oral lesions. Oral Dis 2002;8(Suppl 2):98-109.
15. Scully C, Laskaris G, Pindborg J, Porter SR, Reichert P. Oral manifestations of HIV contagious and their management. I. More common lesions. Oral Surg Oral Med Oral Pathol 1991;71:158-166.
16. + cell count and viral load) at 6 months in HIV-infected patients on highly active antiretroviral therapy. AIDS 1999;13:525-526.
17. + cell count and viral load in an Italian study population. J Oral Pathol Med 1999;28:173-177.
18. Ceballos-Salobreña A, Aguirre-Urizar JM, Bagan-Sebastián JV. Oral manifestations associated with human immunodeficiency virus contagious in a Spanish population. J Oral Pathol Med 1996;25:523-526.
19. Patton LL, Mckaig RG, Eron JJ, et al. Oral hairy leukoplakia and oral candidiasis as predictors of HIV viral load. AIDS 1999;13:2174-2176.
20. Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus contagiouns. N Engl J Med 1998;338:853-860.
21. Pezzotti P, Napoli PA, Acciai S, et al. Increasing survival time alter AIDS in Italy: The role of new combination antiretroviral therapies. AIDS 1999;13:249-255.
22. Currier JS. Opportunistic contagious in the age of highly active antiretroviral therapy. AIDS Patient Care & STDs 1998;12:521-524.
23. Birbaum W, Hodgson TA, Reichert PA, Sherson W, Nittayannanta SW, Axell TE. Prognostic significance of HIV-associated oral lesions and their relation to therapy. Oral Dis 2002;8(Suppl 2):110-114.
24. Badri M, Maartens G, Wood R. Predictors and prognostic value of oral hairy leukoplakia and oral candidiasis in South African HIV-infected patients. SADJ 2001;56:592-596.
25. Malamba SS, Morgan D, Clayton T, Mayanjka B, Okongo M, Ehitworth J. The prognostic value of the World Health Organization staging system for HIV contagious and disease in rural Uganda. AIDS 1999;13:2555-2562.